EYES
Second Sight Medical Products Inc
$24.86
-$0.21(-0.86%)
52
Overall
--
Value
83
Tech
21
Quality
Market Cap
$NaN
Volume
10.04K
52W Range
$25.05 - $28.81
Target Price
$NaN
Order:
Income Statement
| Metric | Trend | Chart | 2012 Dec | 2013 Dec | 2014 Dec | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $1.4M | $1.6M | $3.4M | $8.9M | $4.0M | $8.0M | $6.9M | $3.4M | -- | -- | ||
| OPERATING EXPENSES | ||||||||||||
| Research & development expense | $3.0M | $3.2M | $5.0M | $3.0M | $5.3M | $7.9M | $10.0M | $13.1M | $4.8M | $2.4M | ||
| Amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-16.0M | $-18.0M | $-21.2M | $-20.0M | $-33.2M | $-28.6M | $-34.6M | $-30.6M | $-12.7M | $-8.9M | ||
| EBITDA | $-15.7M | $-17.6M | $-27.9M | $-19.7M | $-32.8M | $-28.2M | $-34.2M | $-30.2M | $-12.5M | $-8.9M | ||
| PRE-TAX INCOME | ||||||||||||
| Total Income available for floaterest expense ( E B I T) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Pre-tax Income ( E B T) | $-16.3M | $-23.0M | $-35.2M | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-14.9M | $-8.9M | ||
| NET INCOME | ||||||||||||
| Net income from total operations | $-16.3M | $-23.0M | $-35.2M | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-14.9M | $-8.9M | ||
| SHARE & EPS DATA | ||||||||||||
| Basic E P S total | $-3.45 | $-4.84 | $-10.35 | $-4.11 | $-6.72 | $-4.24 | $-33.84 | $-18.24 | $-0.72 | $-0.27 | ||
| Diluted E P S total | $-3.45 | $-4.84 | $-10.35 | $-4.11 | $-6.72 | $-4.24 | $-33.84 | $-18.24 | $-0.72 | $-0.27 | ||
| OTHER METRICS | ||||||||||||
| Cost of sales | $4.1M | $5.3M | $3.3M | $5.0M | $9.6M | $4.7M | $4.5M | $1.8M | $-664.0K | $-200.0K | ||
| Gross operating profit | $-3.0M | $-4.1M | $-160.0K | $3.7M | $-6.1M | $2.8M | $2.0M | $1.2M | $500.0K | $130.0K | ||
| Blank | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Gen & administrative expense | $9.9M | $10.7M | $16.0M | $20.7M | $21.8M | $23.6M | $26.6M | $18.7M | $8.3M | $6.7M | ||
| Blank | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Floaterest income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Floaterest expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other income net | $1.8K | $35.0K | $-6.9M | $27.0K | $-1.0K | -- | $-555.0K | $-3.4M | $-2.2M | $2.0K | ||
| Blank | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Income taxes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Minority floaterest | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Total net income | $-16.3M | $-23.0M | $-35.2M | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-14.9M | $-8.9M | ||
| Blank | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Preferred dividends | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Net income available for common | $-16.3M | $-23.0M | $-35.2M | $-20.0M | $-33.2M | $-28.5M | $-35.1M | $-33.6M | $-14.9M | $-8.9M | ||
| Depreciation | $324.7K | $316.0K | $279.0K | $335.0K | $432.0K | $457.0K | $435.0K | $397.0K | $164.0K | $70.0K | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EYES | $24.86 | -0.9% | 10.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Second Sight Medical Products Inc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW